中木国际(01822.HK)附属持股据称被抵押转让 公司表示争议
中木国际(01822.HK)公布,接获Mercury Union注册代理人告知,全资附属公司Genuine Elite所持2.55万股Mercury Union(占後者已发行股份总数的51%),据称已根据2017年11月30日股份抵押转让予Jade Coronet。
有关股份抵押乃Genuine Elite就Jade Coronet根据日
期为2017年11月21日的票据认购协议认购Mercury Union所发行3,000万美元优先担保固定利率票据而以Jade Coronet为受益人设立。
公司对据称股份转让有争议,目前正就此寻求法律意见。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.